SCHEMBL7759024

SCHEMBL7759024

CCCn1c(=O)c2[nH]c(C(C)(C)C)nc2n(CCCN2CCOCC2)c1=O

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 7/20 0.51
▸ ADORA2B P29275 3/20 0.49
▸ SIRT1 Q96EB6 1/20 0.49
▸ SIRT3 Q9NTG7 1/20 0.49
▸ SIRT5 Q9NXA8 1/20 0.49
▸ ADORA2A P29274 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ GMNN O75496 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ PMP22 Q01453 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ PDE2A O00408 1/20 0.45
▸ PDE1A P54750 1/20 0.45
▸ PDE1B Q01064 1/20 0.45
▸ PDE1C Q14123 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7759061 0.89 ADORA1 (0.53) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL7971689 0.82 SIRT1 (0.46) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL8579478 0.81 ADORA1 (0.74) ADORA1ADORA2BADORA2AMEN1GMNN
SCHEMBL7974739 0.80 SIRT1 (0.44) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL3239752 0.78 TLR7 (0.50) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL7760152 0.78 SIRT1 (0.59) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL7759770 0.78 SIRT1 (0.59) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL7759764 0.78 SIRT1 (0.59) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL8836691 0.77 ADORA1 (0.79) ADORA1ADORA2BSIRT1SIRT3SIRT5
SCHEMBL7760165 0.76 ADORA1 (0.68) ADORA1ADORA2BADORA2AMEN1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187780-B1 ANTIDEPRESSANTS, ANTIASTHMATIC AGENTS; MIGRAINE BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-02-13 — — US claimed
EP-1084123-A1 NOVEL ASYMMETRICALLY SUBSTITUTED XANTHINE DERIVATIVES, METHOD FOR PRODUCING THEM AND THEIR USE AS MEDICAMENTS WITH AN ADENOSINE-ANTAGONISTIC EFFECT Boehringer Ingelheim Pharma KG (DE) 2001-03-21 — — EP disclosed
US-6187780-B1 ANTIDEPRESSANTS, ANTIASTHMATIC AGENTS; MIGRAINE BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-02-13 — — US disclosed
WO-1999054331-A1 NOVEL ASYMMETRICALLY SUBSTITUTED XANTHINE DERIVATIVES, METHOD FOR PRODUCING THEM AND THEIR USE AS MEDICAMENTS WITH AN ADENOSINE-ANTAGONISTIC EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-28 — — WO disclosed
Send feedback